The Proposed EU Biotech Act Aims to Accelerate and Streamline Procedures for the Approval of Clinical Trials and Combined Studies
European Commission Announces (Long Awaited) Proposal to Simplify EU Medical Device Regulations
Landmark UK-US Pharmaceutical Deal
MHRA Issues Statement of Policy Intent Regarding Early Access to Innovative Medical Devices
MHRA Announces Consultation Response on Reforms to GB Pre-Market Medical Device Regulation
The Updated NHS Commercial Framework for New Medicines
Re-Launch of UK’s Innovative Licensing and Access Pathway (“ILAP”)
MHRA Consultation on Individualised mRNA Cancer Immunotherapies – Unique opportunity for a streamlined risk based regulatory framework?
